Subscribe free

Cytoreductive Surgery & Peritoneum ·

Gastrectomy achieves long-term survival in advanced pseudomyxoma cases.

Analysis of 120 gastrectomies for appendiceal pseudomyxoma peritonei (PMP) over 20 years revealed a median survival of 104 months and a 10-year overall survival rate of 47%. While complications were observed in 32% of cases, 90-day mortality was low at 1.75%. Outcomes improved over decades, with 82.2% achieving complete cytoreduction (CCR) in the later period, even as the proportion requiring gastrectomy decreased. High-grade disease emerged as a key predictor for survival.

Journal Article by Lord A, Samuel VM (…) Moran B et 6 al. in Ann Surg Oncol

© 2024. Society of Surgical Oncology.

read the whole article in Ann Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Cytoreductive Surgery & Peritoneum.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Cytoreductive Surgery & Peritoneum

The latest stitches

Ann Surg Oncol28 Aug 2026

Prophylactic HIPEC Improves Survival in Advanced Colorectal Cancer

Prophylactic hyperthermic intraperitoneal chemotherapy (HIPEC) significantly enhances peritoneal metastasis-free survival and disease-free survival in patients with locally advanced colorectal cancer, though overall survival rates and complication rates remain unchanged.

All papers in Cytoreductive Surgery & Peritoneum →